CClinicalTrials.gg
CompletedNCT07230704LOWBARUpdated Aug 27, 2026

Effects of Low-Flow and Standard-Flow Sevoflurane Anesthesia on Inflammatory Markers in Bariatric Surgery

An observational study in Obesity, Inflammation and Bariatric Surgery Candidate, sponsored by Adana City Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Adana City Training and Research Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
155
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This retrospective observational study aimed to compare the effects of low-flow and standard-flow sevoflurane anesthesia on perioperative inflammatory responses in patients undergoing laparoscopic sleeve gastrectomy for obesity. Data were obtained from the anesthesia and laboratory records of 155 adult patients who received either low-flow (1 L/min) or standard-flow (4 L/min) sevoflurane anesthesia between January 2022 and January 2025 at Adana City Training and Research Hospital. Preoperative and postoperative inflammatory markers, including C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and red cell distribution width (RDW), were recorded and compared between the two groups. Hemodynamic parameters such as mean arterial pressure and heart rate were also analyzed to assess intraoperative stability. The primary objective of the study was to evaluate the impact of anesthetic flow rate on perioperative inflammation, while the secondary objective was to assess hemodynamic stability during anesthesia. This study may contribute to a better understanding of how low-flow anesthesia influences systemic inflammatory responses and perioperative hemodynamics in morbidly obese patients undergoing bariatric surgery.

Read the detailed description

This retrospective observational cohort study investigated the effects of low-flow and standard-flow sevoflurane anesthesia on perioperative inflammatory markers and hemodynamic stability in patients with obesity undergoing laparoscopic sleeve gastrectomy. The study included 155 adult patients operated between January 2022 and January 2025 at Adana City Training and Research Hospital, Adana, Turkey.

Patients were divided into two groups according to the fresh-gas flow rate used during anesthesia:

Low-flow group: sevoflurane with a total fresh-gas flow rate of 1 L/min,

Standard-flow group: sevoflurane with a total fresh-gas flow rate of 4 L/min.

All patients received general anesthesia as part of routine clinical care. No randomization or intervention was performed by the investigators. Demographic characteristics, anesthesia records, intraoperative hemodynamic parameters (mean arterial pressure, heart rate), and perioperative laboratory results were obtained retrospectively from hospital electronic records.

Preoperative and postoperative (24-hour) values of inflammatory markers-including C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and red cell distribution width (RDW)-were compared within and between groups. The primary endpoint was the change in these inflammatory biomarkers between pre- and postoperative measurements. The secondary endpoint was the comparison of intraoperative hemodynamic stability (MAP and HR variability, incidence of hypotension or bradycardia) between the two groups.

This study aims to provide evidence regarding whether low-flow sevoflurane anesthesia (1 L/min) offers comparable or superior inflammatory and hemodynamic profiles compared with standard-flow anesthesia (4 L/min) in morbidly obese patients. The findings may help optimize anesthetic techniques for bariatric surgery by balancing patient safety, hemodynamic stability, and environmental considerations.

02

Conditions studied

  • Obesity
  • Inflammation
  • Bariatric Surgery Candidate

Keywords

  • Sevoflurane
  • Low-Flow Anesthesia
  • Inflammatory Markers
  • Hemodynamics
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 155 is above the median of 135 across 1,283 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Adana City Training and Research Hospital is the lead sponsor of 17 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Retrospective analysis of 155 adult patients who underwent laparoscopic sleeve gastrectomy under general anesthesia between January 2022 and January 2025 at Adana City Training and Research Hospital. Patients were grouped according to the fresh gas flow rate used during anesthesia (low-flow vs. standard-flow sevoflurane).

Inclusion criteria

  • Adult patients aged 18-60 years
  • Underwent laparoscopic sleeve gastrectomy under general anesthesia
  • Received low-flow or standard-flow sevoflurane anesthesia
  • ASA physical status I-III
  • Complete perioperative records available

Exclusion criteria

Exclusion Criteria:

  • Conversion to open surgery
  • Incomplete or missing data
  • Significant comorbidities (e.g., severe cardiac, hepatic, or renal dysfunction)
  • Perioperative complications unrelated to anesthesia
  • Age \<18 or >60 years
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
155 participants (actual)
Patient registry
No

Groups and cohorts

  • Low-flow Sevoflurane

    Patients who underwent laparoscopic sleeve gastrectomy under general anesthesia with low-flow sevoflurane (fresh gas flow = 1 L/min). Data were obtained retrospectively from hospital records.

  • Standard-flow Sevoflurane

    Patients who underwent laparoscopic sleeve gastrectomy under general anesthesia with standard-flow sevoflurane (fresh gas flow = 4 L/min). Data were obtained retrospectively from hospital records.

06

What researchers measure

Primary outcomes

  1. Change in C-reactive protein (CRP) concentration

    Change in serum C-reactive protein (CRP) levels from preoperative baseline to postoperative 24 hours will be compared between low-flow and standard-flow sevoflurane groups.

    Time frame: From preoperative baseline to postoperative 24 hours

  2. Change in neutrophil-to-lymphocyte ratio (NLR)

    Change in neutrophil-to-lymphocyte ratio (NLR) from preoperative baseline to postoperative 24 hours will be compared between low-flow and standard-flow sevoflurane groups.

    Time frame: From preoperative baseline to postoperative 24 hours

  3. Change in red cell distribution width (RDW)

    Change in red cell distribution width (RDW) from preoperative baseline to postoperative 24 hours will be compared between low-flow and standard-flow sevoflurane groups.

    Time frame: From preoperative baseline to postoperative 24 hours

Secondary outcomes

  1. Mean arterial pressure (MAP) variability

    Change and variability in intraoperative mean arterial pressure (MAP) recorded throughout anesthesia will be compared between low-flow and standard-flow sevoflurane groups.

    Time frame: From induction of anesthesia to end of anesthesia

  2. Heart rate (HR) variability

    Change and variability in intraoperative heart rate (HR) recorded throughout anesthesia will be compared between low-flow and standard-flow sevoflurane groups.

    Time frame: From induction of anesthesia to end of anesthesia

07

Study locations

1 site
  • Adana City Training and Research Hospital
    Adana, Adana 010650, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — The datasets generated and analyzed during the current study are not publicly available due to institutional data protection policies.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07230704
Lead sponsor
Adana City Training and Research Hospital
Responsible party
Uğur serkan Çitilcioğlu (Principal Investigator, Department of Anesthesiology, Adana City Training and Research Hospital) — Principal investigator
First posted
Nov 17, 2025
Start date
Jan 1, 2022
Primary completion
Jan 31, 2025
Completion
Jan 31, 2025
Last update
Aug 27, 2026

Study contacts

Ugur serkan Citilcioglu, MD
principal investigator · Adana City Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion